New Tool: ProSource
Check out our packaging and processing solutions finder, ProSource.

Experimental Stem Cell Therapy Reduces Seizures in Epileptic Patients

The approach involves injecting inhibitory neurons from human embryonic stem cells into the focal point of the patients' seizures.

Screen Shot 2022 04 18 At 2 41 24 Pm
Getty Images

According to a recent article from The Guardian, two epilepsy patients who participated in an early trial of an experimental stem cell therapy saw a significant reduction in seizures after receiving a single brain injection of lab-grown neurons. The therapy, developed by Neurona Therapeutics, aims to dampen abnormal electrical activity in the brain to control seizures. 

After a year of treatment, both patients showed promising results, with one patient achieving a more than 95% reduction in seizures and the other a more than 90% reduction, along with improved cognitive function. These early findings suggest the potential of this non-destructive treatment approach as an alternative for people with epilepsy who don’t respond well to medication or aren’t great candidates for surgery.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts